US FDA Advisory Committee Open Public Hearing Changes Urged

 
• By Sue Sutter
  
Microphone
Stakeholders disagree about the shortfalls in the existing open public hearing process. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers